On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
We are very excited to launch our new website! Please take a few moments to click around and explore...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...